Literature DB >> 19709497

Percutaneous left ventricular assist devices during cardiogenic shock and high-risk percutaneous coronary interventions.

Stéphane Cook1, Stephan Windecker.   

Abstract

Left ventricular assist devices were developed to support the function of a failing left ventricle. Owing to recent technological improvements, ventricular assist devices can be placed by percutaneous implantation techniques, which offer the advantage of fast implantation in the setting of acute left ventricular failure. This article reviews the growing evidence supporting the clinical use of left ventricular assist devices. Specifically, we discuss the use of left ventricular assist devices in patients with cardiogenic shock, in patients with acute ST-elevation myocardial infarction without shock, and during high-risk percutaneous coronary interventions.

Entities:  

Mesh:

Year:  2009        PMID: 19709497     DOI: 10.1007/s11886-009-0051-7

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN: 1523-3782            Impact factor:   2.931


  62 in total

1.  Thoratec VAD system as a bridge to heart transplantation.

Authors:  D J Farrar; J H Lawson; P Litwak; G Cederwall
Journal:  J Heart Transplant       Date:  1990 Jul-Aug

2.  Percutaneous left ventricular assist device in acute myocardial infarction and cardiogenic shock.

Authors:  William Merhi; Simon R Dixon; William W O'Neill; George S Hanzel; Peter A McCullough
Journal:  Rev Cardiovasc Med       Date:  2005       Impact factor: 2.930

3.  Mechanical left ventricular unloading prior to reperfusion reduces infarct size in a canine infarction model.

Authors:  Hela Achour; Fernando Boccalandro; Patricia Felli; James Amirian; Margaret Uthman; Maximillian Buja; Richard W Smalling
Journal:  Catheter Cardiovasc Interv       Date:  2005-02       Impact factor: 2.692

4.  Improved regional myocardial blood flow, left ventricular unloading, and infarct salvage using an axial-flow, transvalvular left ventricular assist device. A comparison with intra-aortic balloon counterpulsation and reperfusion alone in a canine infarction model.

Authors:  R W Smalling; D B Cassidy; R Barrett; B Lachterman; P Felli; J Amirian
Journal:  Circulation       Date:  1992-03       Impact factor: 29.690

5.  Percutaneous ventricular assist device support in a patient with a postinfarction ventricular septal defect.

Authors:  Igor D Gregoric; Mark C Bieniarz; Harvinder Arora; O H Frazier; Biswajit Kar; Pranav Loyalka
Journal:  Tex Heart Inst J       Date:  2008

6.  Feasibility and long-term safety of elective Impella-assisted high-risk percutaneous coronary intervention: a pilot two-centre study.

Authors:  Francesco Burzotta; Leonardo Paloscia; Carlo Trani; Marco Mascellanti; Rocco Mongiardo; Guido Materazzo; Giampaolo Niccoli; Massimo Di Marco; Antonio Maria Leone; Italo Porto; Mario Attilio Mazzari; Antonio Giuseppe Rebuzzi; Giovanni Schiavoni; Filippo Crea
Journal:  J Cardiovasc Med (Hagerstown)       Date:  2008-10       Impact factor: 2.160

7.  The TandemHeart, percutaneous transseptal left ventricular assist device: a safeguard in high-risk percutaneous coronary interventions. The six-year Rotterdam experience.

Authors:  Pascal Vranckx; Emanuele Meliga; Peter P T De Jaegere; Martin Van den Ent; Evelyn S Regar; Patrick W Serruys
Journal:  EuroIntervention       Date:  2008-11       Impact factor: 6.534

8.  Treatment of acute myocardial infarction with cardiogenic shock using left ventricular assist device.

Authors:  H Noda; H Takano; Y Taenaka; T Nakatani; M Umezu; M Kinoshita; E Tatsumi; A Yagura; H Sekii; Y Kito
Journal:  Int J Artif Organs       Date:  1989-03       Impact factor: 1.595

9.  Use of the percutaneous left ventricular assist device in patients with severe refractory cardiogenic shock as a bridge to long-term left ventricular assist device implantation.

Authors:  Gary M Idelchik; Leo Simpson; Andrew B Civitello; Pranav Loyalka; Igor D Gregoric; Reynolds Delgado; Biswajit Kar
Journal:  J Heart Lung Transplant       Date:  2008-01       Impact factor: 10.247

10.  A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction.

Authors:  Melchior Seyfarth; Dirk Sibbing; Iris Bauer; Georg Fröhlich; Lorenz Bott-Flügel; Robert Byrne; Josef Dirschinger; Adnan Kastrati; Albert Schömig
Journal:  J Am Coll Cardiol       Date:  2008-11-04       Impact factor: 24.094

View more
  2 in total

1.  Outcomes of pre-emptive and rescue use of percutaneous left ventricular assist device in patients with structural heart disease undergoing catheter ablation of ventricular tachycardia.

Authors:  Nilesh Mathuria; Geru Wu; Francia Rojas-Delgado; Mossaab Shuraih; Mehdi Razavi; Andrew Civitello; Leo Simpson; Guilherme Silva; Suwei Wang; MacArthur Elayda; Bharat Kantharia; Steve Singh; O H Frazier; Jie Cheng
Journal:  J Interv Card Electrophysiol       Date:  2016-08-06       Impact factor: 1.900

Review 2.  Treatment of ventricular tachycardia in patients with heart failure.

Authors:  Michael W Fong; Luanda Grazette; David Cesario; Michael Cao; Leslie Saxon
Journal:  Curr Cardiol Rep       Date:  2011-06       Impact factor: 2.931

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.